Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Early biomarkers of joint damage in rheumatoid and psoriatic arthritisSoluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placeboIdentification of urinary peptide biomarkers associated with rheumatoid arthritis.Infliximab: 12 years of experienceIn vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis.The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study.MRI identifies plantar plate pathology in the forefoot of patients with rheumatoid arthritis.The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritisCartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.Cells of the synovium in rheumatoid arthritis. Chondrocytes.Methodology and applications of disease biomarker identification in human serum.Tomosynthesis can facilitate accurate measurement of joint space width under the condition of the oblique incidence of X-rays in patients with rheumatoid arthritis.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Dose optimization of infliximab in patients with rheumatoid arthritis.Biomarkers of cartilage and surrounding joint tissue.Associations between serum biomarkers and pain and pain-related function in older adults with low back pain: a pilot study.Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
P2860
Q27687777-9E091FB2-99EF-43EE-AAD9-C3C84B7E2E07Q28083506-CFEDF3C2-ECD9-4F66-A86F-99E60B2BB1F8Q28475485-63D66E78-3D53-47AB-9774-B015AD2748C3Q34075303-EDBC10FD-0F42-4933-87F1-60E31AEF7E8AQ35070446-A40F13D5-86BF-410F-9F36-736EE687D9C0Q35103645-9A72AD85-7FD3-457A-B0F2-0634AD91CD8AQ35557805-E47C8E38-1A23-4105-A42B-64D7EAF891DCQ35759047-E5AB5772-956C-4F4A-BCC5-BD64E6564FADQ35859141-D0D7038E-2518-4660-93F2-2B5852034617Q36274389-754008B0-AF51-4317-A035-1D917253D38BQ36401945-03AE4632-A73F-4CE5-9805-26D66D26F27EQ36493865-BAB0A202-C394-4CA6-BA04-D802C87CAD24Q36631211-B1852485-DFFF-468F-8AA5-AB4169BF1FFDQ37000837-A2F3A649-8EFA-4FDE-A79A-C7A2E6BEDC7AQ37574961-12C34CC2-55A2-4A80-9CFB-89DF3E20BC14Q37601101-6B109557-66ED-4F0D-B20D-F4C78DA4FF5EQ37677789-363C467C-0616-4F4D-A5A2-ACDB51BE0B41Q38182728-1D0C3DD6-9DD1-4FB0-B8A0-A14AC208997BQ38239828-D5B5603F-ED40-4DFF-8171-551804FD8C30Q39103745-F3460BE9-097B-4BA7-A8EA-729D9C29C98CQ42136310-F6917C30-A40B-472F-97D7-7743F9B106ACQ54339705-DD870036-8D16-4271-A8E4-2CB0619B4BC8
P2860
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@ast
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@en
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@nl
type
label
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@ast
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@en
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@nl
prefLabel
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@ast
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@en
Radiographic joint damage in r ...... 1 to 4 years after diagnosis.
@nl
P2093
P2860
P356
P1476
Radiographic joint damage in r ...... m 1 to 4 years after diagnosis
@en
P2093
D M Hofman
F P J G Lafeber
J W J Bijlsma
Utrecht Rheumatoid Arthritis Cohort Study group (SRU)
P2860
P2888
P356
10.1186/AR1882
P577
2006-01-10T00:00:00Z